Advanced Search
Contact | Corporate | Help

Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer

Sponsors:
  • Hoosier Oncology Group
  • Genentech
  • Eli Lilly and Company
  • Walther Cancer Institute
Phases:
  • Phase II
IndicationsAcronym:
  • Bladder Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Cisplatin
  • Drug: Gemcitabine
  • Drug: Bevacizumab
Enrollment:
45

Additional information about NCT00234494.


SourceSolution © 2008-2012